GSK-1292263 is an orally available GPR119 agonist with pEC50s of 6.9 and 6.7 for human and rat GPR119, respectively. GSK-1292263 can be used for the research of type 2 diabetes mellitus (T2DM)[1].
Molecular Weight:
456.56
Purity:
99.71
CAS Number:
[1032823-75-8]
Formula:
C23H28N4O4S
Target:
GPR119
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted